PLANNED MAINTENANCE

There will be scheduled maintenance work beginning on Wednesday 26th February 2020 from 11:00 AM through to 12.00 PM (GMT).

During this time, you may not be able to log into ChemSpider. We apologise for any inconvenience this might cause and thank you for your patience.


ChemSpider 2D Image | Omipalisib | C25H17F2N5O3S

Omipalisib

  • Molecular FormulaC25H17F2N5O3S
  • Average mass505.496 Da
  • Monoisotopic mass505.102020 Da
  • ChemSpider ID25027388

More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

1086062-66-9 [RN]
1X8F5A3NA0
2,4-Difluor-N-{2-methoxy-5-[4-(4-pyridazinyl)-6-chinolinyl]-3-pyridinyl}benzolsulfonamid [German] [ACD/IUPAC Name]
2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide
2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide
2,4-Difluoro-N-{2-méthoxy-5-[4-(4-pyridazinyl)-6-quinoléinyl]-3-pyridinyl}benzènesulfonamide [French] [ACD/IUPAC Name]
2,4-Difluoro-N-{2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide [ACD/IUPAC Name]
9901
Benzenesulfonamide, 2,4-difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]- [ACD/Index Name]
GSK 2126458
More...
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Safety:

      5 Axon Medchem 1596
      H303;H313;H317;H333;H334;H335;H373 Axon Medchem 1596
      no pictogram Axon Medchem 1596
      P101;P102;P103;P260;P262;P263;P264;P270;P280;P304;P312;P340 Axon Medchem 1596
      Warning Axon Medchem 1596
    • Target Organs:

      PI3K inhibitor; mTOR inhibitor TargetMol T1861
    • Bio Activity:

      GSK2126458 is a highly selective and potent inhibitor of PI3K with Ki of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110?/?/?/?, mTORC1/2 , respectively.; IC50 value: 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM (p110?/?/?/?, mTORC1/2) [1]; Target: p110?/?/?/?; mTORC1/2; in vitro: ; Target: GSK2126458 potently inhibits the activity of common activating mutants of p110? (E542K, E545K, and H1047R) found in human cancer with Ki of 8 pM, 8 pM and 9 pM, respectively [1]. MedChem Express HY-10297
      mTOR MedChem Express HY-10297
      mTOR PI3K MedChem Express HY-10297
      p110??/??/??/??, mTORC1/2 TargetMol T1861
      PI3K/Akt/mTOR MedChem Express HY-10297
      PI3K/Akt/mTOR ; MedChem Express HY-10297
      PI3K/Akt/mTOR Signaling TargetMol T1861

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.5±0.1 g/cm3
Boiling Point: 715.6±70.0 °C at 760 mmHg
Vapour Pressure: 0.0±2.3 mmHg at 25°C
Enthalpy of Vaporization: 104.6±3.0 kJ/mol
Flash Point: 386.6±35.7 °C
Index of Refraction: 1.660
Molar Refractivity: 128.7±0.4 cm3
#H bond acceptors: 8
#H bond donors: 1
#Freely Rotating Bonds: 6
#Rule of 5 Violations: 1
ACD/LogP: 3.81
ACD/LogD (pH 5.5): 3.31
ACD/BCF (pH 5.5): 189.38
ACD/KOC (pH 5.5): 1446.07
ACD/LogD (pH 7.4): 2.44
ACD/BCF (pH 7.4): 25.37
ACD/KOC (pH 7.4): 193.73
Polar Surface Area: 115 Å2
Polarizability: 51.0±0.5 10-24cm3
Surface Tension: 65.1±3.0 dyne/cm
Molar Volume: 348.6±3.0 cm3

Click to predict properties on the Chemicalize site






Advertisement